Adjusted regression coefficients (β) of CCL13, CCL11, and CCL26 levels with relapse times, ARR, and EDSS scores as outcomes in neuromyelitis optica spectrum disorder patients. The gene discussed is CCL11; the disease is neuromyelitis optica.